Drug Type Small molecule drug, Diagnostic radiopharmaceuticals |
Synonyms- |
Action agonists, modulators |
Mechanism H3 receptor agonists(Histamine H3 receptor agonists), σ1 receptor modulators(Sigma opioid receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuralgia | Preclinical | United States | 27 May 2026 | |
| Neuralgia | Preclinical | United Kingdom | 27 May 2026 |





